MBX Biosciences, Inc. (MBX)
53.49
+0.39
(+0.73%)
USD |
NASDAQ |
Nov 18, 16:00
54.20
+0.71
(+1.33%)
After-Hours: 20:00
MBX Biosciences Price to Book Value : 5.614 for Nov. 18, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 17, 2026 | 5.573 |
| November 16, 2026 | 5.576 |
| November 13, 2026 | 5.872 |
| November 12, 2026 | 5.721 |
| November 11, 2026 | 6.058 |
| November 10, 2026 | 5.912 |
| November 09, 2026 | 5.674 |
| November 06, 2026 | 5.390 |
| November 05, 2026 | 5.086 |
| November 04, 2026 | 5.508 |
| November 03, 2026 | 5.773 |
| November 02, 2026 | 5.710 |
| October 30, 2026 | 5.864 |
| October 29, 2026 | 5.724 |
| October 28, 2026 | 5.685 |
| October 27, 2026 | 5.560 |
| October 26, 2026 | 5.278 |
| October 23, 2026 | 5.091 |
| October 22, 2026 | 5.296 |
| October 21, 2026 | 5.660 |
| October 20, 2026 | 5.615 |
| October 19, 2026 | 5.508 |
| October 16, 2026 | 5.207 |
| October 15, 2026 | 5.323 |
| October 14, 2026 | 5.124 |
| Date | Value |
|---|---|
| October 13, 2026 | 5.143 |
| October 12, 2026 | 5.46 |
| October 09, 2026 | 5.588 |
| October 08, 2026 | 5.589 |
| October 07, 2026 | 5.724 |
| October 06, 2026 | 5.974 |
| October 05, 2026 | 6.144 |
| October 02, 2026 | 6.141 |
| October 01, 2026 | 5.936 |
| September 30, 2026 | 6.153 |
| September 29, 2026 | 6.762 |
| September 28, 2026 | 6.737 |
| September 25, 2026 | 6.279 |
| September 24, 2026 | 6.485 |
| September 23, 2026 | 6.778 |
| September 22, 2026 | 7.257 |
| September 21, 2026 | 7.135 |
| September 18, 2026 | 7.366 |
| September 17, 2026 | 7.480 |
| September 16, 2026 | 7.209 |
| September 15, 2026 | 7.151 |
| September 14, 2026 | 6.965 |
| September 11, 2026 | 6.910 |
| September 10, 2026 | 7.135 |
| September 09, 2026 | 7.366 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ligand Pharmaceuticals, Inc. | 6.218 |
| Xeris Biopharma Holdings, Inc. | 63.58 |
| ANI Pharmaceuticals, Inc. | 2.497 |
| Corcept Therapeutics, Inc. | 8.883 |
| Veru, Inc. | 1.388 |
Price to Book Value Related Metrics
| PEG Ratio | -0.6281 |
| Price | 53.49 |
| Earnings Yield | -5.72% |
| Market Cap | 2.655B |
| PEGY Ratio | -0.6281 |